The account of the user that owns this channel has been inactive for the last 5 months. If it remains inactive in the next 10 days, that account will self-destruct and this channel will no longer have an owner.

Channel
Reprodução Humana | Genomic Summit
@genomicsummitreproducao
On this record: Growth · Engagement · What this channel posts · Posts · Polls · Cite this entry
66subscribers
+0 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
Register entry
| Telegram ID | -1001232290272 |
|---|---|
| Type | Channel |
| Username | @genomicsummitreproducao |
| Created | Between 1 March 2018 and 27 August 2020 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 10 August 2026 |
| Last confirmed live | 7 September 2026 |
| Measurements held | 4 |
| Confirmed unchanged | 3 times, most recently 7 September 2026 |
| On Telegram | t.me/genomicsummitreproducao |
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 24 Aug 2026, 04:48 | 66 | -1 |
| 16 Aug 2026, 20:56 | 67 | +1 |
| 10 Aug 2026, 01:46 | 66 | no change |
| 7 Aug 2026, 21:13 | 66 | first reading |
Engagement
19 posts held, back to 27 August 2020 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 19 posts for this entry, the most recent from 7 May 2021. An engagement rate over an empty window would be a number about nothing.
What this channel posts
- Video runtime
- 1m 30s
- Average length
- 1m 30s
Measured directly from 1 video with a duration reading, out of the posts we hold for this channel — not this channel’s whole posting history, only the sample this register has actually read. An exact reading to the second, taken from the post itself rather than from Telegram’s own rounded chrome, so it carries no ≈ mark.
Recent posts
The account of the user that owns this channel has been inactive for the last 5 months. If it remains inactive in the next 17 days, that account will self-destruct and this channel will no longer have an owner.
A Chromosome Powered by GeneOne em parceria com o GEIC - Grupo de Estudo em Infertilidade Conjugal, convida você para um encontro virtual o tema: O que os médicos devem saber sobre a Progesterona na suplementação da fase lútea nas técnicas de Reprodução Assistida. Palestrante: Paul Peitte (Head of Scientifc Affairs and Consult at Besins Healthcare Global) Data: 25 de Março Horário: 18h Inscreva-se: http://bit.ly/G…
Photo, posted without a caption
Na quinta-feira, 29 de outubro, às 19h, teremos um encontro virtual com a Dra. Anna Luiza Lobão Gonçalves sobre Miomectomia nas pacientes inférteis. Será transmitido pelo ZOOM e para participar é necessário se inscrever pelo link: https://bit.ly/2GSwUSw
"Genomic Summit GeneOne" foi o evento que teve destaque mundial nas últimas semanas Foram 3 dias evento totalmente interativo e gratuito. Tivemos mais de + 8mil profissionais inscritos na plataforma, + de 25 países conectados ao evento + de 6 mil visitas nos estandes dos patrocinadores #myriad #natera #guardant #thermofisher #dasa #alvaroapoio .... INCRÍVEL! E se você quer assistir ou rever na integra os melhores mo…
Esta foi a edição 2020 do Genomic Summit GeneOne. Agradecemos sua participação ativa em nosso evento e esperamos vê-los em breve!
O último dia do Genomic Summit GeneOne será marcado por palestras nas áreas de cardiologia, doenças raras e neurologia. Acompanhe a seleção de convidados que preparamos para explorar os temas mais relevantes do momento.
E chega ao fim a agenda com alguns dos nomes mais renomados da área. Não conseguiu acompanhar todas as palestras que queria? Ficou interessado em duas mesas que aconteceriam no mesmo horário? Todo o material ficará disponível na íntegra pelo canal de YouTube da GeneOne: https://www.youtube.com/channel/UCJv4QaHLxJr5-3nN9ZysCrA
E nossa imersão em conhecimento termina com a sua avaliação. Qual a sua opinião sobre o conteúdo apresentado na palestra?
- Muito relevante71%
- Relevante29%
- Pouco relevante0%
Shares as published. No per-option vote count is published by Telegram, so none is shown.
Encerramos nossos conteúdos sobre reprodução humana e medicina fetal com excelência. A Dra. Hitomi Miura e o Dr. Adelino Amaral Silva vão debater agora o estado da arte da reprodução assistida no Brasil. Vamos?
No último intervalo do dia, aproveitamos para lembrar que o evento não acaba hoje. Amanhã ainda teremos conteúdos exclusivos sobre cardiologia, doenças raras e neurologia. Acompanhe!
Showing the 12 most recent of 19 posts we hold for @genomicsummitreproducao. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Polls
The 4 polls we hold for this entry, as Telegram rendered them when we read the post. A poll’s figures keep moving after that, so each one is dated.
E nossa imersão em conhecimento termina com a sua avaliação. Qual a sua opinião sobre o conteúdo apresentado na palestra?
- Muito relevante71%
- Relevante29%
- Pouco relevante0%
Shares as published. No per-option vote count is published by Telegram, so none is shown.
Com mais uma palestra chegando ao fim, vem a hora da avaliação. Qual a sua opinião sobre o conteúdo apresentado?
- Muito relevante75%
- Relevante20%
- Pouco relevante5%
Shares as published. No per-option vote count is published by Telegram, so none is shown.
E então, o que você achou da palestra do Dr. Russ Jelsema sobre suas descobertas na Natera Inc.?
- Muito relevante76%
- Relevante24%
- Pouco relevante0%
Shares as published. No per-option vote count is published by Telegram, so none is shown.
Como foi a sua imersão em testes não invasivos? Contamos com a sua opinião para trazer conteúdos atualizados e interessantes:
- Muito relevante72%
- Relevante24%
- Pouco relevante4%
Shares as published. No per-option vote count is published by Telegram, so none is shown.
Percentages only — there are no per-option vote counts here, because Telegram publishes none. The public post preview gives each option’s share and a single voter total, and nothing else. Multiplying one by the other would produce a per-option tally that looks measured and is not: the shares are rounded to whole numbers before we ever see them. We print what was published and leave the column that does not exist empty.
The shares need not add up to 100. Rounding alone puts many polls at 99 or 101. A poll that allows more than one answer per voter runs well past 100 by design, and several here do. The bars are drawn against a fixed 100% track at each option’s own percentage rather than normalised to the total, so a poll that exceeds it shows that it does instead of being quietly rescaled.
Read from the 19 most recent posts we hold, published 27 August 2020 to 7 May 2021. Telegram labels each poll by kind — an anonymous poll, a quiz, a closed set of final results — and that label is reproduced rather than paraphrased.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 24 August 2026 — this entry's latest reading, not the date you are reading this.
“Reprodução Humana | Genomic Summit” (@genomicsummitreproducao), 66 subscribers as measured 24 August 2026. Telegram Register, tgregister.com/channel/genomicsummitreproducao.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.